NOT-NS-19-047: Notice of Change to Key Date for PAR-19-167 "Development and Validation of Advanced Mammalian Models for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)".

Notice of Change to Key Date for PAR-19-167 "Development and Validation of Advanced Mammalian Models for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)"

Notice Number: NOT-NS-19-047

Key Dates
Release Date: March 11, 2019

Related Announcements
PAR-19-167

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to inform applicants of a change to the Advisory Council Review Date in PAR-19-167 "Development and Validation of Advanced Mammalian Models for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)". The Advisory Council Review Date will change from August 2019 to October 2019.

Currently Reads:

Part 1. Overview

Key Dates

Advisory Council Review

August 2019

Modified to Read:

Part 1. Overview

Key Dates

Advisory Council Review

October 2019

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Amelie Gubitz, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-5680
Email:gubitza@ninds.nih.gov